Skip to content
10-K

Annual Report

Glucotrack, Inc. GCTK

0001493152-26-013656

← back to feed
Filed
Mar 30, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 30, 2026 1.94M sh
Shares Diluted FY 2025 · Dec 31, 2025 621.09K sh
Shares Diluted restated FY 2025 · Dec 31, 2024 5.5K sh
Capex FY 2025 · Dec 31, 2025 $96K
Capex FY 2025 · Dec 31, 2024 $104K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$15.24M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$12.49M
Cash And Equivalents FY 2025 · Dec 31, 2025 $7.38M
Cash And Equivalents FY 2025 · Dec 31, 2024 $5.62M
Stockholders Equity FY 2025 · Dec 31, 2025 $2.83M
Stockholders Equity FY 2025 · Dec 31, 2024 −$13M
Stockholders Equity FY 2025 · Dec 31, 2023 $3.2M
Current Liabilities FY 2025 · Dec 31, 2025 $4.77M
Current Liabilities FY 2025 · Dec 31, 2024 $1.28M
Total Liabilities FY 2025 · Dec 31, 2025 $5.01M
Total Liabilities FY 2025 · Dec 31, 2024 $18.93M
Current Assets FY 2025 · Dec 31, 2025 $7.67M
Current Assets FY 2025 · Dec 31, 2024 $5.77M
Total Assets FY 2025 · Dec 31, 2025 $7.84M
Total Assets FY 2025 · Dec 31, 2024 $5.93M
Eps Diluted FY 2025 · Dec 31, 2025 $31.22
Eps Diluted restated FY 2025 · Dec 31, 2024 $4,106.00
Eps Basic FY 2025 · Dec 31, 2025 $31.22
Eps Basic restated FY 2025 · Dec 31, 2024 $4,106.00
Rd Expense FY 2025 · Dec 31, 2025 $9.81M
Rd Expense FY 2025 · Dec 31, 2024 $9.5M
Net Income FY 2025 · Dec 31, 2025 −$19.39M
Net Income FY 2025 · Dec 31, 2024 −$22.6M
Operating Income FY 2025 · Dec 31, 2025 −$16.09M
Operating Income FY 2025 · Dec 31, 2024 −$14.55M